Helen developed key skills in organisation and communication through experience in both private and public sector work before joining the University in May 2010.
Since then she has delivered strategic support and project management to research proposals and programmes in biomedical studies, with a growing focus on miscarriage and global women’s health.
Her current role underpins an outstanding portfolio of qualitative research, international clinical trials and evidence synthesis work, supporting Professor Arri Coomarasamy in his leadership of ventures including Tommy’s National Centre for Miscarriage Research. Other studies include the recently completed PROMISE Trial to explore the role of progesterone therapy for recurrent miscarriage; the PRISM Trial to consider progesterone therapy for women with early pregnancy bleeding; and the Carbetocin RTS Trial investigates the role of carbetocin to prevent postpartum haemorrhage.
Helen is also a co-applicant to a Health Technology Assessment award to conduct a network meta-analysis and cost-effectiveness analysis of uterotonic agents to prevent postpartum haemorrhage.